Point72 Hong Kong LTD Stoke Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $2,537 - $4,551	-202 Reduced 10.99%	1,636 $21,000
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $5,677 - $13,113	548 Added 42.48%	1,838 $24,000
Q1 2022 May 16, 2022	BUY	$17.19 - $26.1 $22,175 - $33,669	1,290 New	1,290 $27,000
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $32,234 - $46,941	-1,363 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$30.53 - $41.09 $41,612 - $56,005	1,363 New	1,363 $46,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $386M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.